Viemed Healthcare, Inc. cash flow to debt ratio of 325.53% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Viemed Healthcare, Inc.'s free cash flow has increased 805.24% from $1.32M last year to $11.93M, signaling increasing performance

Viemed Healthcare, Inc.'s debt to equity ratio is 0.08, which means that the company's assets are healthy financed, signaling financial stability.

Viemed Healthcare, Inc.'s debt has increased relative to shareholder equity from 0.05 last year to 0.08 today, signaling weakened financials

Viemed Healthcare, Inc. has a net debt to EBITDA ratio of 0.05x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Viemed Healthcare, Inc.'s interest coverage ratio of 17.25 indicates that earnings with good margin can cover interest payments on company debt

Viemed Healthcare, Inc.'s profit margin has decreased (4.31%) in the last year from 5.02% to 4.81%, signaling decreasing performance

Viemed Healthcare, Inc.'s short-term assets of $48.49M exceed its short-term liabilities of $41.06M

Viemed Healthcare, Inc.'s return on assets of 7.10% is higher than the 5.00% threshold, indicating efficient asset utilization

Viemed Healthcare, Inc.'s return on equity of 10.30%, is lower than 15.00%, indicating bad performance

Viemed Healthcare, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Viemed Healthcare, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Viemed Healthcare, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Viemed Healthcare, Inc. has a free cash flow yield of 3.36%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Viemed Healthcare, Inc.'s yearly earnings has increased 32.57% since last year from $11.27M to $14.93M, signaling increasing performance

Viemed Healthcare, Inc.'s yearly revenue has increased 20.52% since last year from $224.26M to $270.28M, signaling increasing performance

ROIC 11.00% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Viemed Healthcare, Inc.'s 3-year revenue CAGR of 24.87% is positive, indicating growing revenue over the past 3 years

Viemed Healthcare, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Viemed Healthcare, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Viemed Healthcare, Inc. is overvalued relative to its fair value price of 2.11 based on Discounted Cash Flow model

Viemed Healthcare, Inc. has an earnings yield of 4.07%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Viemed Healthcare, Inc. is overvalued relative to its fair value price of 9.09 based on EBITDA multiple model

Viemed Healthcare, Inc. has an EV/EBITDA ratio of 6.93x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Viemed Healthcare, Inc. is overvalued relative to its fair value price of 9.00 based on Earnings Fair Value model

Viemed Healthcare, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Viemed Healthcare, Inc. has a price-to-book ratio of 2.44x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Viemed Healthcare, Inc. has a price-to-sales ratio of 1.18x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue